AU2003216389A1 - Induction of hair growth with vascular endothelial growth factor - Google Patents

Induction of hair growth with vascular endothelial growth factor

Info

Publication number
AU2003216389A1
AU2003216389A1 AU2003216389A AU2003216389A AU2003216389A1 AU 2003216389 A1 AU2003216389 A1 AU 2003216389A1 AU 2003216389 A AU2003216389 A AU 2003216389A AU 2003216389 A AU2003216389 A AU 2003216389A AU 2003216389 A1 AU2003216389 A1 AU 2003216389A1
Authority
AU
Australia
Prior art keywords
induction
vascular endothelial
growth factor
hair growth
hair
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003216389A
Other versions
AU2003216389A8 (en
Inventor
Michael Dake
Jacob Waugh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revance Therapeuticals Inc
Original Assignee
Essentia Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Essentia Biosystems Inc filed Critical Essentia Biosystems Inc
Publication of AU2003216389A8 publication Critical patent/AU2003216389A8/en
Publication of AU2003216389A1 publication Critical patent/AU2003216389A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0241—Containing particulates characterized by their shape and/or structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/88—Polyamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
AU2003216389A 2002-02-21 2003-02-21 Induction of hair growth with vascular endothelial growth factor Abandoned AU2003216389A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35940002P 2002-02-21 2002-02-21
US60/359,400 2002-02-21
PCT/US2003/005564 WO2003072049A2 (en) 2002-02-21 2003-02-21 Induction of hair growth with vascular endothelial growth factor

Publications (2)

Publication Number Publication Date
AU2003216389A8 AU2003216389A8 (en) 2003-09-09
AU2003216389A1 true AU2003216389A1 (en) 2003-09-09

Family

ID=27766077

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003216389A Abandoned AU2003216389A1 (en) 2002-02-21 2003-02-21 Induction of hair growth with vascular endothelial growth factor

Country Status (2)

Country Link
AU (1) AU2003216389A1 (en)
WO (1) WO2003072049A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040220100A1 (en) * 2000-07-21 2004-11-04 Essentia Biosystems, Inc. Multi-component biological transport systems
WO2006121610A2 (en) * 2005-05-05 2006-11-16 Genencor International, Inc. Personal care compositions and methods for their use
AU2011253597B2 (en) * 2004-03-03 2014-12-04 Revance Therapeutics, Inc. Multi-component biological transport systems
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
CA3031270A1 (en) * 2004-03-03 2005-12-22 Revance Therapeutics, Inc. Compositions and methods for topical diagnostic and therapeutic transport
EP1861112A4 (en) 2005-03-03 2009-07-22 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
JP2008531725A (en) 2005-03-03 2008-08-14 ルバンス セラピュティックス インク． Compositions and methods for topical application and transdermal delivery of oligopeptides
US8197865B2 (en) 2005-08-09 2012-06-12 Access Business Group International Llc Methods and compositions for modulating hair growth or regrowth
CN101842107B (en) 2007-07-26 2014-04-23 雷文斯治疗公司 Antimicrobial peptide, compositions , and methods of use
SI3031825T1 (en) 2008-03-14 2019-12-31 Allergan, Inc. Immuno-based botulinum toxin serotype a activity assays
CN102791284A (en) * 2010-02-24 2012-11-21 艾德宛金国际私人有限公司 Method of treatment or prevention of hair loss or for the enhancement of hair growth
ITRM20110406A1 (en) * 2011-07-28 2013-01-29 Giuliani Spa PLANTARICINE AND BIOMASS INCLUDING PLANTARS FOR USE IN THE COSMETIC AND MEDICAL FIELD.
WO2014066916A2 (en) 2012-10-28 2014-05-01 Revance Therapeutics, Inc. Compositions and methods for safe treatment of rhinitis
US11484580B2 (en) 2014-07-18 2022-11-01 Revance Therapeutics, Inc. Topical ocular preparation of botulinum toxin for use in ocular surface disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4078060A (en) * 1976-05-10 1978-03-07 Richardson-Merrell Inc. Method of inducing an estrogenic response
CA2416289C (en) * 2000-07-21 2012-12-04 Essentia Biosystems, Inc. Multi-component biological transport systems

Also Published As

Publication number Publication date
AU2003216389A8 (en) 2003-09-09
WO2003072049A2 (en) 2003-09-04
WO2003072049A3 (en) 2004-03-25

Similar Documents

Publication Publication Date Title
AU2002252631A1 (en) Vascular endothelial growth factor 2
AU2002333623A1 (en) Antisense modulation of vascular endothelial growth factor receptor-1 expression
WO2002083850A8 (en) Vascular endothelial growth factor 2
AU2003300323A1 (en) Vascular prosthesis and methods of use
EP1581147A3 (en) Vascular prosthesis and methods of use
AU2003206949A1 (en) Venous prosthesis
AU2003259271A1 (en) Bipolar articles and related methods
AU2002360467A1 (en) Antisense modulation of connective tissue growth factor expression
AU2003249366A1 (en) Silk biomaterials and methods of use thereof
AU2003295801A1 (en) MODULATION OF HIF1Alpha AND HIF2Alpha EXPRESSION
AU2003253690A1 (en) Silk biomaterials and methods of use thereof
WO2005072417A3 (en) Vascular endothelial growth factors and methods of their use
AU2003237875A1 (en) Antisense modulation of apolipoprotein b expression
AU5023300A (en) Vascular endothelial growth factor variants
AU2003216389A1 (en) Induction of hair growth with vascular endothelial growth factor
AU2003275026A1 (en) Induction of insulin expression
AU2003300862A1 (en) Modulation of endothelial lipase expression
AU2004226467A8 (en) Reduction of hair growth
AU2003221663A1 (en) Hair growth
AU2002365202A1 (en) Synthetic genes for malarial proteins and methods of use
AU2002313770A1 (en) Vascular endothelial growth factor 2
AU2003245262A1 (en) Reduction of hair growth
AU2002342355A1 (en) Identifying and controlling the growth of estrogen-responsive cells
AU5903600A (en) A novel vascular endothelial growth factor family member and uses thereof
AU2003220805A1 (en) Antiopoietin-related growth factor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase